Read the #TenTweetNephJC summary of the ADMIRAL study, examining how dd-cfDNA monitoring may help us manage our patients with renal transplants.

1. Does transplant medicine have a new blood test that is better than creatinine?

Aye aye ADMIRAL 🫡

Join us as we recap last week's #NephJC chat on this edition of #TenTweetNephJC brought to you by @jamiekwillows and @michaelturk6 pic.twitter.com/gAS70VKG8i
— Nephrology Jrnl Club (@NephJC) July 1, 2022